- Home
- ALZN vs STRR Comparison
ALZN vs STRR Comparison
Compare ALZN & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- STRR
- Stock Information
- Founded
- ALZN 2016
- STRR 1985
- Country
- ALZN United States
- STRR United States
- Employees
- ALZN N/A
- STRR N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALZN Health Care
- STRR Health Care
- Exchange
- ALZN Nasdaq
- STRR Nasdaq
- Market Cap
- ALZN 6.1M
- STRR 7.0M
- IPO Year
- ALZN 2021
- STRR N/A
- Fundamental
- Price
- ALZN $0.69
- STRR $2.15
- Analyst Decision
- ALZN Strong Buy
- STRR
- Analyst Count
- ALZN 1
- STRR 0
- Target Price
- ALZN $32.00
- STRR N/A
- AVG Volume (30 Days)
- ALZN 869.9K
- STRR 5.6K
- Earning Date
- ALZN 03-10-2025
- STRR 03-20-2025
- Dividend Yield
- ALZN N/A
- STRR N/A
- EPS Growth
- ALZN N/A
- STRR N/A
- EPS
- ALZN N/A
- STRR N/A
- Revenue
- ALZN N/A
- STRR $50,375,000.00
- Revenue This Year
- ALZN N/A
- STRR $15.58
- Revenue Next Year
- ALZN N/A
- STRR $36.27
- P/E Ratio
- ALZN N/A
- STRR N/A
- Revenue Growth
- ALZN N/A
- STRR 2.22
- 52 Week Low
- ALZN $0.66
- STRR $2.05
- 52 Week High
- ALZN $15.06
- STRR $5.35
- Technical
- Relative Strength Index (RSI)
- ALZN 24.21
- STRR 46.40
- Support Level
- ALZN $0.66
- STRR $2.12
- Resistance Level
- ALZN $0.93
- STRR $2.45
- Average True Range (ATR)
- ALZN 0.07
- STRR 0.18
- MACD
- ALZN -0.01
- STRR 0.00
- Stochastic Oscillator
- ALZN 9.00
- STRR 25.00
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.